How many investments has VI Partners made?

VI Partners has 44 tracked investments, 2 of which have exited, including 4 dated in the last 24 months.

What stage does VI Partners invest at?

VI Partners invests at the Seed, Series A stages.

What is VI Partners's typical check size?

VI Partners typically writes checks of $2.2M – $4.5M.

Where is VI Partners located?

VI Partners is headquartered in Altendorf, CH.

Does VI Partners lead rounds?

Yes, VI Partners leads investment rounds.

Who does VI Partners co-invest with?

VI Partners most often shares deals with Daniel Gutenberg, Andera Partners, SICTIC, among 76 tracked co-investors.

VI Partners

Venture capital

Altendorf · Seed–Series A · 16 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into VI Partners

4,917 people in our graph can introduce you to the VI Partners team.

Paths you didn't know you had: your email and LinkedIn already hold routes to the VI Partners team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

VI Partners positions itself as a partner to founders building category-defining companies in Switzerland and Europe. With more than 25 years of experience funding and supporting innovative companies, the firm invests at the Seed and Series A stages and often acts as a lead investor. It emphasizes bringing deep industry expertise and hands-on strategic support to boards and founders, drawing on the operational experience of its managing partners to help companies scale through subsequent rounds.

Invests inAI & Machine Learning Biotech Deep Tech Enterprise Software Healthtech Medical Devices SaaS Europe Switzerland

Source: firm website, verified Aug 3, 2026.

Leave your own feedback

Stage

Seed–Series A

Check

$2.2M – $4.5M

Altendorf, CH

Leads rounds

Leads

Instruments

Equity

Founded

2001

Last 12 months

1 investment

AUM

$102.6M

Tracked investments

Unicorns

Acquisitions

Team · 16 people

from the firm's website & public directories

Alain Nicod· Founder & Senior Advisor· Bagnes, Valais, Switzerlandin

Alain Nicod joined VI Partners in 2002 after investing from 1989 to 2002 in medical instrumentation, IT, and consumer companies, frequently as founder, early-stage investor, or executive. He previously advised telecom operators on cable TV, interactive services, and M&A, and began his career at Arthur Andersen and McKinsey.

alain@vipartners.ch

Arnd Kaltofen· Managing Partner· Zurich, Switzerlandin

Arnd Kaltofen has extensive experience building and exiting healthcare ventures, having served as chairman or board director of companies including Esbatech, Kuros Biosurgery, Activaero and Ganymed Pharmaceuticals. Previously he led healthcare venture capital transactions at KPMG Corporate Finance and worked in medical device and digital health startups; he is a trained MD with an MBA and a postgraduate degree in computer science.

arnd@vipartners.ch

Cyrill Osterwalder· Operating Partner· Zurich, Switzerlandin

Operating Partner at VI Partners focused on technology investments. Previously a senior security and privacy engineering lead at Google (2010-2018), and before that VP of web application security at Phion (acquired by Barracuda Networks in 2009); he co-founded and led Visonys as CTO/CEO. He holds a master's in computer science from ETH Zurich and has been an early private investor in the cryptocurrency and blockchain ecosystem since 2013.

cyrill@vipartners.ch

Diego Braguglia· Managing Partner· Altendorf, Schwyz, Switzerlandin

Diego Braguglia has over two decades of venture capital experience creating, growing, and exiting companies in therapeutics and medical devices. He has served as chairman, non-executive director, or board observer at several companies including Endoart, Endosense, Picodrill, Neocutis, Amal, Sequana, and Genkyotex, and previously managed medical device and pharmaceutical companies. He holds an M.Sc. in Microbiology from the University of Basel and a PhD in Molecular and Cellular Biology from ISREC in Lausanne.

diego@vipartners.ch

Gaetano Zanon· Managing Partner· Switzerlandin

Investor and entrepreneur with 20 years of experience. Before VI Partners he spent 15 years in London in M&A and founded an alternative asset manager focused on environmental assets, advising corporations, sovereign wealth funds and private equity firms, and later held C-level roles at Swiss financial institutions. Holds an MBA from IMD and is a CFA charterholder.

gaetano@vipartners.ch

Julien Pache· Partner· Switzerlandin

Julien Pache has over 15 years of experience as a VC investor and operator. He spent nearly a decade at Verve Ventures leading the investment team and backing 25+ early-stage SaaS and deep tech companies, served as CCO of Bring! Labs, and holds master's degrees in Law (University of Fribourg) and Philosophy of Science (University of Bern).

Olivier Laplace· Managing Partner· Switzerlandin

Olivier Laplace has around 18 years of experience as a tech entrepreneur, software developer, investment banker, and VC investor. Before VI Partners he was Investment Director at Swiss Post, launching its corporate VC activity, and previously worked at Kudelski, JPMorgan, and Citigroup; he holds an MBA from IMD.

olivier@vipartners.ch

Magdalena Plotcyk· Principal

Daniel Gutenberg· Venture Partner· Zurich, Zurich, Switzerlandin

Daniel Gutenberg joined VI Partners in July 2003 with a focus on IT and now serves as a Venture Partner. He founded Gutenberg Communication Systems AG in 1991, served as its CEO, and sold it to the Telindus Group in 2000, after which he became an active business angel investing globally in unicorns. He holds several board seats in public and private companies.

daniel@vipartners.ch

Bruno Trivelli· Investment Analyst· Zürich Metropolitan Areain

Bruno brings a background in strategy consulting, technical innovation, and business management. He holds a Master's in Robotics with a minor in Management Technology and Entrepreneurship from EPFL, previously interned at Deloitte in technology strategy, founded a mobile tech startup in Lausanne, and completed his MSc thesis at Harvard's Microrobotics Lab.

bruno@vipartners.ch

Elmar Schärli· Finance Manager

Irene Seebacher· Finance & Operations Manager· Zurich, Zurich, Switzerlandin

Maria Escala-Garcia· Investment Associate· Lausanne, Vaud, Switzerlandin

Maria has a multidisciplinary background in digital health, medtech, and biotech, holding a PhD in bioinformatics and oncology from the Netherlands Cancer Institute and Leiden University. Before Vi Partners she advised healthcare stakeholders at IQVIA on precision medicine and digital health strategy and previously worked in healthtech.

Martina Gromo· Investment Associate· Zurich, Zurich, Switzerlandin

Martina Gromo is an Investment Associate at VI Partners with a background in strategy consulting, fintech, and digital innovation. She holds a double master's in International Management from Bocconi and Banking and Finance from the University of St. Gallen, and previously worked at Sygnum Bank, Bain & Company, and N26.

martina@vipartners.ch

Susan M. Gasser· Advisor, healthcare and life sciences

Yassine Zaied· Operating Partner· Lausanne, Vaud, Switzerlandin

A SaaS veteran and former C-level executive at Nexthink, where he helped establish the Digital Employee Experience (DEX) management category. He supports portfolio companies with go-to-market expertise and category creation.

Founder mafia

2 people who came through VI Partners went on to found or lead other companies.

Olivier LaplaceManaging PartnerFounded Founders Pledge John LunnFintech AdvisorFounded Gr4Vy

What they invest in

from 30 of 44 portfolio companies

AI & Machine Learning ×14SaaS ×14Biotech ×12Healthtech ×12Medical Devices ×12Enterprise Software ×7Fintech ×5Deep Tech ×4

HQs:Switzerland×11Germany×5United States×4Belgium×1France×1United Kingdom×1

Who they back

founder profiles across 16 portfolio companies

25%

solo founders

4 of 16 mapped founding teams

22%

repeat founders

of 18 founders with career history

Founding team size:solo founder×42 founders×43 founders×44+ founders×4

Where their founders studiedfrom 19 founders with education data

University of St.Gallen ×3CentraleSupélec ×2

What their founders studiedfrom 17 founders with field-of-study data

Computer Science ×5Engineering ×4Business & Management ×2Economics ×2Physics ×2

Where their founders worked beforefrom 18 founders with career history

SAP ×3Merantix ×2Merck Serono ×2Simon-Kucher & Partners ×2

Investments · 44 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 2 2024 · 2 2022 · 3 2021 · 1 2019 · 2 2015 · 112 dated

Araris Biotechararisbiotech.com✓ verified

Araris develops proprietary antibody-drug conjugate (ADC) linker technology that enables one-step attachment of payloads to native antibodies for targeted cancer therapy.

BiotechMedical DevicesBasel, CH

Dragan Grabulovski(Co-founder and CEO)inPhilipp Spycher(Co-founder and Chief Scientific Officer)inIsabella Attinger-Toller(Co-founder)in

Co-investorsPureos Bioventures redalpine Samsung Ventures b2venture Kinled Holding 4BIO Capital

Sequana Medicalsequanamedical.com in 𝕏✓ verifiedDefunct

Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsKreos Capital Newton Biocapital BlackRock EQT Life Sciences Rosetta Capital Ltd.Bootstrap Europe +3 more

Sibyllasibyllabiotech.it in 𝕏Oct 2022✓ verified

Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.

AI & Machine LearningBiotechDeep TechTrento, IT

Emiliano Biasini(Co-founder)in Pietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)in Maria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)

Co-investors3B Future Health Fund CDP Venture Capital Seroba Life Sciences V-Bio Ventures Vertis SGR Claris Ventures +1 more

JenaValvejenavalve.comJul 2015 · $62.5M

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.

Digital HealthHealthtechMedical DevicesIrvine, US

Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)

BoardErik Amble(Director)

Board seat Arnd Kaltofen· per SEC Form D

Co-investorsAndera Partners Bain Capital Life Sciences Rosetta Capital Ltd.Atlas Venture Gimv Innovatus Capital Partners +5 more

Acodisacodis.io in

Acodis provides AI-powered document automation and data extraction for quality and compliance teams, primarily in regulated industries like pharmaceuticals and life sciences.

AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareLegalTechSaaS

Co-investorsBackbone Ventures Kickstart Innovation Seed X Serpentine Ventures SICTIC

Airspeedgoairspeed.com inJun 2021

Airspeed builds AI-first products, applying generative AI and large language models to enterprise applications.

AI & Machine LearningEnterprise SoftwareSaaSSales TechVancouver, US

Doug Camplejohn(Executive Officer, Director, Promoter)Adam Liska(Co-Founder & CEO)inDevang Agrawal(Co-Founder & CTO)in

Co-investorsAtlassian Ventures Framework Venture Partners Creator Fund DN Capital Greylock Partners Point72 Ventures

Airspeedairspeed.ai

Adam Liska(Founder)Devang Agrawal(Founder)

Co-investorsDN Capital Framework Venture Partners

Almeralmer.com in 𝕏

Almer offers the RealWear Arc 3, an assisted-reality head-mounted device with a dual-camera system, precision display, and AI-powered guided workflows for hands-free field work.

AI & Machine LearningEnterprise SoftwareHardware

Co-investorsKickfund

Altoidaaltoida.com in 𝕏May 2019 · $6.3M

Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsAlpana Ventures Daniel Gutenberg Eisai Innovation, Inc.Hikma Ventures M Ventures Polytech Ecosystem Ventures +3 more

Buynomicsbuynomics.com in

Buynomics builds a Virtual Shoppers AI that integrates multiple data sources to predict shopper behavior and support commercial and pricing decisions for enterprises.

AI & Machine LearningRetail TechSaaSSales Tech

Ingo(Founder/Managing Director)Sebastian Baier(Founder)inDr. Ingo Reinhardt(Founder/Managing Director)Anton Von Lampe(COO)in Mario Koenigsfeld(VP of Revenue)inPiotr Malinski(VP Engineering)in

Co-investorsAnais Ventures DvH Ventures Forestay Capital Insight Partners La Famiglia Tomahawk.VC

Glyphicglyphic.ai

AI copilot for sales teams analyzing customer interactions and optimizing revenue strategies

Adam Liska(Founder)Devang Agrawal(Founder)

Co-investorsFJ Labs Point72 Ventures Artis Ventures Atlassian Ventures Creator Fund DN Capital +1 more

Highlife Medicalhighlifemedical.com in

HighLife develops a transcatheter mitral valve replacement (TMVR/TSMVR) technology for patients with moderate to severe mitral regurgitation, implanted in a beating heart while preserving the native valve structure.

BiotechHealthtechMedical DevicesParis, FR

Georg Börtlein(Founder)in Malek Nasr(Founder)inRüdiger Lange(Founder (Heart Surgeon))Nicolo Piazza(Founder (Interventional Cardiologist))Stefan Pilz(CEO)inStephen Brecker(Chief Medical Officer)in

Co-investorsAndera Partners Sofinnova Partners US Venture Partners

iOncturaionctura.com in 𝕏Jun 2024 · $86M

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.

BiotechDeep TechHealthtechMedical Devices

Catherine Pickering(Co-Founder & CEO)in Lars van der Veen(Co-Founder & CSO)in Michael Lahn(CMO)in Elizabeth Holt(CBO)inSteven Sciuto(CFO)in Michelle Tsai(COO)in

Co-investorsInkef 3B Future Health Fund M Ventures XGEN Venture Johnson & Johnson Innovation – JJDC

Kadoakadoa.com inMar 2025

Kadoa provides web data collection and curation for businesses, particularly investment firms.

AI & Machine LearningData & InfrastructureDeveloper ToolsFintechSaaSZurich, CH

Johannes Engler(Founder)inTavis Lochhead(Founder)in

Co-investorsAIX Ventures FYRFLY Venture Partners

Kuros Bioscienceskurosbio.com in

Kuros Biosciences is a Swiss biotech company developing biologic technologies for bone healing and bone grafts, primarily for spine, extremities, and pelvis surgical applications.

BiotechHealthtechMedical Devices

Chris Fair(CEO)in

Co-investorsDaniel Gutenberg

Leaseteqleaseteq.com in

LEASETEQ develops a car financing platform and aims to build a vehicle financing ecosystem in Europe.

FintechMobility & TransportationSaaS

Anna Rosenbauer(CXO & Co-Founder)inJOSCHA ROSENBAUER(CEO, Co-Founder, Mitglied Verwaltungsrat)

Co-investorsArmada Investment AG Daniel Gutenberg Monte Carlo Capital SICTIC

Ledgyledgy.com in 𝕏Sep 2022 · $22M

Ledgy is a platform for managing non-cash compensation, including equity, deferred compensation, carried interest, pensions, and savings, with features for share plan administration, vesting schedules, cross-jurisdiction compliance reporting, and employee-facing dashboards.

FintechHR TechSaaSZürich, CH

Armon Bättig(Co-Founder & CEO)inYoko Spirig(Founder)inTimo Horstschäfer(Co-Founder & CTO)Ben Brandt(Founder)Timo Horstschaefer(Founder)

Co-investors20VC Creathor Ventures Daniel Gutenberg New Enterprise Associates (NEA)Sequoia Capital Visionaries Club +2 more

Merlionmerlionpharma.com

MerLion Pharma is a pharmaceutical company engaged in the non-clinical and clinical development of drug candidates.

BiotechHealthtechBerlin, DE

Dr. Andreas Vente(Co-founder & Managing Director)

Morgenmorgen.so in 𝕏

Morgen is a calendar and task management app that consolidates calendars from Google, Outlook, Apple, and Fastmail and schedules tasks from tools like Notion, ClickUp, Linear, and Todoist, with an AI Planner that recommends and adapts daily plans.

AI & Machine LearningFuture of WorkSaaSZürich, CH

David Tedaldi(Founder)inMarco Ancona(Founder)Markus Gross(Founder)

Co-investorsSICTIC

Nexthinknexthink.com

Nexthink is a software company that provides IT departments with real-time analytics, automations, and employee feedback tools to improve digital workplace experiences.

Enterprise SoftwareFuture of WorkSaaS

Patrick Hertzog(Founder)Pedro Bados(Founder)Vincent Bieri(Founder)

Co-investorsAdelie Daniel Gutenberg Forestay Capital Galdana Ventures Highland Europe Index Ventures +4 more

Ninoxninox.com in 𝕏

Ninox is an AI-native low-code platform that lets teams build custom business software without coding.

AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSBerlin, DE

Frank Böhmer(Founder)in

Co-investorsMatterwave Ventures Techstars Hi Inov IBB Ventures

Oculisoculis.com in

Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments.

BiotechHealthtechMedical DevicesBoston, CH

Riad Sherif(Chief Executive Officer)in

Co-investorsBay City Capital Brunnur Ventures GP Pivotal Life Sciences BVCF

Oplitoplit.com in

Oplit provides a supply chain planning platform that uses optimization algorithms and agentic AI to continuously recompute production plans in real time across factories.

Advanced ManufacturingAI & Machine LearningSaaS

Thibaut Wilhelm(Founder)in

Co-investorsKima Ventures Newfund Capital OSS Ventures Evolem

Picterrapicterra.ai inApr 2022 · $6.5M

Picterra provides a GeoAI platform that analyzes geospatial data from satellites, drones, and aerial imagery to deliver environmental intelligence for applications in agriculture, forestry, infrastructure, and energy sectors.

AgTechAI & Machine LearningClimate TechData & Infrastructure

Co-investorsAtlantic ACE & Company Atlantic Labs

Skribbleskribble.com in 𝕏

Skribble provides a digital electronic signature service that lets users sign documents online with certified and legally recognized signatures.

Enterprise SoftwareLegalTechSaaS

Philipp Dick(Founder)in

Co-investorsActon Capital Daniel Gutenberg b2venture Übermorgen Ventures

Somagenetixsomagenetix.com inOct 2024

Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source.

BiotechDeep TechHealthtechMedical DevicesZurich, CH

Co-investorsVerve Ventures

Sumupsumup.com in 𝕏

SumUp provides card readers and payment solutions such as invoices, gift cards, and payment links aimed at small merchants and businesses that are underserved by traditional banks.

FintechHardwareRetail TechSaaSLondon, GB

Victor Ho inDaniel Klein(Founder)Jan Deepen(Founder)Marc-Alexander Christ(Founder)Petter Made(Founder)Stefan Jeschonnek(Founder)

Co-investorsAlexander Geza Marcus Pejacsevich Anya Capital Bain Capital Tech Opportunities Daniel Gutenberg Discovery Ventures III Gmb H & Co. KG Fin Capital +19 more

Tactiva Therapeuticstactivatherapeutics.com

Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients.

BiotechHealthtechMedical DevicesChicago, US

Richard C. Koya(Co-Founder)Kunle Odunsi(Co-Founder)Jay Zhang(CEO)

Co-investorsEFung Capital Panacea Venture

Uniqueunique.ch inFeb 2025

Unique provides a platform that accelerates business processes and go-to-market initiatives through generative AI applications and consulting expertise for enterprise clients.

AI & Machine LearningEnterprise SoftwareFintechSaaSZurich, CH

Andreas Hauri(Founder)in Manuel Grenacher(Founder)in Michelle Heppler(Founder)in

Co-investorsCommerzVentures Daniel Gutenberg DN Capital Kickstart Innovation FYRFLY Venture Partners Pictet Group +1 more

Varavara.ai in

Vara AI develops clinically validated AI tools for breast imaging that assist radiologists in detecting cancers earlier and improving diagnostic accuracy.

AI & Machine LearningHealthtechMedical DevicesBerlin, DE

Jonas Muff(CEO)inStefan Bunk(CTO)in

Co-investorsIBB Ventures Merantix Capital Smart Family Office

Xeltisxeltis.com in 𝕏Aug 2026

Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.

BiotechDeep TechHealthtechMedical Devices

Eliane Schutte(Chief Executive Officer)in

Co-investorsKurma Partners Ysios Capital Amadeus Capital Partners EQT Life Sciences Invest-NL

Xo Lifexo-life.com in

XO Life operates a digital platform connecting patients, healthcare providers, pharmaceutical companies, and medical professionals to improve treatment access and outcomes through shared health insights and technological infrastructure.

AI & Machine LearningDigital HealthHealthtechSaaS

Sergey Vasilyev(Chief Technology Officer)in Zdenka Vesely(Chief Client Officer)in

Co-investorsBayern Kapital Grazia Equity GmbH Sandwater FRC FUND MANAGEMENT S.À R.L.

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ab2 BioAmalAMAL Therapeutics SAArarisBreast cancer screening DiscoverFlowitGamayaInositecMedLumicsMilaNeocutisVisonys

Exits · 2

2 acquisitions

Ararisacq. by Taiho PharmaceuticalVisonysacq. by phion AG

Portfolio news

latest coverage across their companies

Xeltis raises an additional €20.5m of funding to advance

Xeltis · globenewswire.com · Jul 28, 2026

CSBT.F - How a Mispriced Medtech Engine is Disrupting $5,000 Bone Graft Giants.

Kuros Biosciences · simplywall.st · Jul 26, 2026

Airspeed Raises $20M in Series A Funding

Airspeed · finsmes.com · Jun 4, 2026

Frequently asked questions

How many investments has VI Partners made?: VI Partners has 44 tracked investments, 2 of which have exited, including 4 dated in the last 24 months.
What stage does VI Partners invest at?: VI Partners invests at the Seed, Series A stages.
What is VI Partners's typical check size?: VI Partners typically writes checks of $2.2M – $4.5M.
What sectors does VI Partners focus on?: VI Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Enterprise Software, Healthtech, Medical Devices, SaaS.
Where is VI Partners located?: VI Partners is headquartered in Altendorf, CH.
Does VI Partners lead rounds?: Yes, VI Partners leads investment rounds.
Who does VI Partners co-invest with?: VI Partners most often shares deals with Daniel Gutenberg, Andera Partners, SICTIC, among 76 tracked co-investors.

Media · Podcasts & interviews

featuring the team

🇨🇭 Alain Nicod // VI Partners // Venture Capital Talk by qashqade // Episode #9

Curated · Alain Nicod

Images

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Blackbird Ventures

Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.

$149K – $60M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.